Literature DB >> 11224055

Differential effects of d-fenfluramine, l-fenfluramine and d-amphetamine on the microstructure of human eating behaviour.

J. McGuirk1, E. Goodall, T. Silverstone, P. Willner.   

Abstract

An observational technique, demonstrated to provide reliable data under a variety of conditions, was used to evaluate the effects of d-fenfluramine, l-fenfluramine, d-amphetamine, and fenfluramine-amphetamine combinations on eating behaviour in human subjects. Following an overnight fast, subjects ate lunch from a dispenser allowing free access to a choice of ten sweet and savoury foods, of varying macronutrient composition. D-fenfluramine (30mg) and d-amphetamine (15mg) reduced food intake; l-fenfluramine (30mg) was essentially inactive. The net effects of d-fenfluramine and d-amphetamine on food intake were additive, but the behavioural mechanisms of action were different for the two drugs. D-amphetamine decreased the duration of the meal, as well as the time spent chewing or manipulating food and the number of bites, but had no effect on eating rate; by contrast, d-fenfluramine decreased the rate of eating, but had no effect on meal duration.

Entities:  

Year:  1991        PMID: 11224055

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  16 in total

1.  Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence.

Authors:  J McGuirk; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Relevance of animal models to human eating disorders and obesity.

Authors:  Regina C Casper; Elinor L Sullivan; Laurence Tecott
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

3.  A serotonin and melanocortin circuit mediates D-fenfluramine anorexia.

Authors:  Yong Xu; Juli E Jones; Danielle A Lauzon; Jason G Anderson; Nina Balthasar; Lora K Heisler; Andrew R Zinn; Bradford B Lowell; Joel K Elmquist
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

Review 4.  Neural control of energy balance: translating circuits to therapies.

Authors:  Laurent Gautron; Joel K Elmquist; Kevin W Williams
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

Review 5.  Central nervous control of energy and glucose balance: focus on the central melanocortin system.

Authors:  Yong Xu; Joel K Elmquist; Makoto Fukuda
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

6.  Serotonin mediated changes in corticotropin releasing factor mRNA expression and feeding behavior isolated to the hypothalamic paraventricular nuclei.

Authors:  Joanne P Boisvert; Tyler J Boschuetz; Jon M Resch; Christopher R Mueller; Sujean Choi
Journal:  Neurosci Lett       Date:  2011-05-11       Impact factor: 3.046

7.  Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement model.

Authors:  Charles L Pickens; Carlo Cifani; Brittany M Navarre; Hila Eichenbaum; Florence R Theberge; Michael H Baumann; Donna J Calu; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2011-12-03       Impact factor: 4.530

8.  Leptin and post-prandial satiety: acute central leptin more potently reduces meal frequency than meal size in the rat.

Authors:  Eric P Zorrilla; Koki Inoue; Glenn R Valdez; Antoine Tabarin; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2004-07-27       Impact factor: 4.530

9.  A comparison of the effects of d- and l-fenfluramine and d-amphetamine on energy and macronutrient intake in human subjects.

Authors:  E Goodall; S Feeney; J McGuirk; T Silverstone
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 10.  Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.

Authors:  Elizabeth K Nousen; Juliana G Franco; Elinor L Sullivan
Journal:  Neuroendocrinology       Date:  2013-09-21       Impact factor: 4.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.